AU8515598A - Peripheral nervous system specific sodium channel peptide (PNS SCP) modulating agent and bioassay therefor, treatment of diseases mediated by PNS SCP, and computer molecular modeling of PNS SCP - Google Patents

Peripheral nervous system specific sodium channel peptide (PNS SCP) modulating agent and bioassay therefor, treatment of diseases mediated by PNS SCP, and computer molecular modeling of PNS SCP

Info

Publication number
AU8515598A
AU8515598A AU85155/98A AU8515598A AU8515598A AU 8515598 A AU8515598 A AU 8515598A AU 85155/98 A AU85155/98 A AU 85155/98A AU 8515598 A AU8515598 A AU 8515598A AU 8515598 A AU8515598 A AU 8515598A
Authority
AU
Australia
Prior art keywords
pns scp
bioassay
therefor
treatment
nervous system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU85155/98A
Other versions
AU715138B2 (en
Inventor
Laurence A Borden
Simon Halegoua
Gail Mandel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Shire NPS Pharmaceuticals Inc
Original Assignee
Research Foundation of State University of New York
NPS Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU41434/96A external-priority patent/AU697465B2/en
Application filed by Research Foundation of State University of New York, NPS Pharmaceuticals Inc filed Critical Research Foundation of State University of New York
Publication of AU8515598A publication Critical patent/AU8515598A/en
Application granted granted Critical
Publication of AU715138B2 publication Critical patent/AU715138B2/en
Assigned to RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, THE, NPS PHARMACEUTICALS, INC. reassignment RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, THE Alteration of Name(s) in Register under S187 Assignors: RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK, THE, TROPHIX PHARMACEUTICALS, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU85155/98A 1994-11-02 1998-09-16 Peripheral nervous system specific sodium channel peptide (PNS SCP) modulating agent and bioassay therefor, treatment of diseases mediated by PNS SCP, and computer molecular modeling of PNS SCP Ceased AU715138B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33402994A 1994-11-02 1994-11-02
US08/334029 1994-11-02
US48240195A 1995-06-07 1995-06-07
US08/482401 1995-06-07
AU41434/96A AU697465B2 (en) 1994-11-02 1995-11-02 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU41434/96A Division AU697465B2 (en) 1994-11-02 1995-11-02 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof

Publications (2)

Publication Number Publication Date
AU8515598A true AU8515598A (en) 1998-11-26
AU715138B2 AU715138B2 (en) 2000-01-20

Family

ID=27154073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85155/98A Ceased AU715138B2 (en) 1994-11-02 1998-09-16 Peripheral nervous system specific sodium channel peptide (PNS SCP) modulating agent and bioassay therefor, treatment of diseases mediated by PNS SCP, and computer molecular modeling of PNS SCP

Country Status (1)

Country Link
AU (1) AU715138B2 (en)

Also Published As

Publication number Publication date
AU715138B2 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
AU2429397A (en) Polymerized staphylococcal protein a for treatment of diseases
AU5422396A (en) Method for treatment of autoimmune diseases using interferon-tau
AU695692B2 (en) Nasal mask
AU3560495A (en) Medicament inhaler
AU7048596A (en) Grounded electrode medical implement and system
AU5268696A (en) Novel compounds and methods for therapy
AU5025396A (en) Computer based medical procedure simulation system
AU1688797A (en) Computer-assisted surgical system
AU7867994A (en) Hemofiltration of mediator-related diseases
AU7397994A (en) Improved patient/nurse call system
AU6913796A (en) Patient treatment apparatus
AU5945296A (en) Medicament for nasal administration
AU4853096A (en) Face mask
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU8800598A (en) B7-binding molecules for treating immune diseases
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
AU4873197A (en) Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
AU4775693A (en) Peptide medicaments for treating disease
AU5175796A (en) Method of identifying molecules that regulate fgf activity
AU1059095A (en) Treatment of viral disease with cd40l peptide
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU5847194A (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU7072896A (en) Dna encoding medicinal proteins
AU2242897A (en) Protein occlusion for delivery of small molecules
AU7498296A (en) Use of protein gax for treating cancer

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)